83408-85-9 Usage
Description
1-(1H-benzoimidazol-2-ylsulfanyl)-2-[(4-nitrophenyl)amino]ethanone is a complex organic compound characterized by the presence of a benzimidazole ring with a thiol group, attached to a 2-carbon chain that is further connected to a 4-nitrophenylamino group. This structural composition endows the compound with potential interactions with biological targets, such as enzymes or receptors, which may be harnessed in various applications within the fields of pharmacology and medicinal chemistry.
Uses
Used in Pharmaceutical Industry:
1-(1H-benzoimidazol-2-ylsulfanyl)-2-[(4-nitrophenyl)amino]ethanone is used as a potential therapeutic agent for targeting specific biological pathways. Its unique structure allows for the possibility of modulating enzyme or receptor activity, which could be beneficial in the development of new drugs to treat various diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-(1H-benzoimidazol-2-ylsulfanyl)-2-[(4-nitrophenyl)amino]ethanone serves as a valuable compound for further research and development. Its structural features make it a promising candidate for the design and synthesis of novel drugs, particularly those aimed at addressing unmet medical needs or improving upon existing treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 83408-85-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,4,0 and 8 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 83408-85:
(7*8)+(6*3)+(5*4)+(4*0)+(3*8)+(2*8)+(1*5)=139
139 % 10 = 9
So 83408-85-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H12N4O3S/c20-14(9-16-10-5-7-11(8-6-10)19(21)22)23-15-17-12-3-1-2-4-13(12)18-15/h1-8,16H,9H2,(H,17,18)
83408-85-9Relevant articles and documents
Synthesis and CNS Activity of 2-(N-Arylaminoacetylmercapto)- and 2-(N-Arylacetamidomercapto)-benzimidazoles
Tripathi, Shephali,Ahmad, Shakeel,Barthwal, J. P.,Kishor, K.,Tangri, K. K.,Bhargava, K. P.
, p. 379 - 380 (2007/10/02)
The title mercaptobenzimidazoles (1a-t) have been synthesised and screened for their anticonvulsant and monoamine oxidase (MAO) inhibitory activities.Some of the compounds provide 80percent protection against pentylenetetrazole-induced convulsions and max
